Bal Pharma Ltd

Board of Directors at their meeting held on 13.02.2024 has inter alia 1.Taken on record and approved Unaudited stand alone and consolidated financial results for the quarter and 9 months ended 31.12.2024.2. Differed to consider fund raising options due to unfavorable and volatile market conditions.